Literature DB >> 32162036

Genetic polymorphisms and multiple myeloma risk: a meta-analysis.

Pengcheng Zhang1,2,3, Bing Liu4,5.   

Abstract

Previous researches exploring associations between multiple myeloma (MM) and genetic polymorphisms showed controversial results. In this investigation, we aimed to make a meta-analysis to assess the association between MM risk and genetic polymorphisms. We searched for articles on genetic polymorphism and MM risk in Web of Science and PubMed databases from 1951 to August 2019. We computed the odds ratio (OR) and 95% confidence intervals (CI) extracted from included articles. The meta-analysis showed no significant associations between MM risks and tumor necrosis factor (TNF)-α (rs1800629/rs361525/rs1799724), interleukin (IL)-6 (rs1800795), multidrug resistance 1 (MDR1) (rs1045642), Methylenetetrahydrofolate reductase (MTHFR) (rs1801131/rs1801133) polymorphisms. In summary, the study shows that the TNF-α (rs1800629/rs361525/rs1799724), IL-6 (rs1800795), MDR1 (rs1045642), and MTHFR (rs1801131/rs1801133) polymorphisms may not be associated with MM susceptibility. Thus, we do not need more expensive and useless studies to explore the associations between MM risks and these genetic polymorphisms.

Entities:  

Keywords:  Interleukin-6; Methylenetetrahydrofolate reductase; Multidrug resistance 1; Multiple myeloma; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2020        PMID: 32162036     DOI: 10.1007/s00277-020-03979-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  34 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  Multiple myeloma.

Authors:  Antonio Palumbo; Kenneth Anderson
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

3.  Haplotypes in the tumour necrosis factor region and myeloma.

Authors:  Gareth J Morgan; Peter J Adamson; Fiona K Mensah; Charlotte F Spink; Graham R Law; Leigh J Keen; Eve Roman; Faith E Davies; Sara Rollinson; J A Child; Jeffrey L Bidwell
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

Review 4.  Multiple myeloma: a review of the epidemiologic literature.

Authors:  Dominik D Alexander; Pamela J Mink; Hans-Olov Adami; Philip Cole; Jack S Mandel; Martin M Oken; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2007       Impact factor: 7.396

Review 5.  Pathobiology and Diagnosis of Multiple Myeloma.

Authors:  Kevin Brigle; Barbara Rogers
Journal:  Semin Oncol Nurs       Date:  2017-07-05       Impact factor: 2.315

6.  Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma.

Authors:  Baidarbhi Chakraborty; Gaurav Vishnoi; Srinivas H Gowda; Binita Goswami
Journal:  Asia Pac J Clin Oncol       Date:  2014-10-31       Impact factor: 2.601

7.  Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.

Authors:  Juan Du; Zhengang Yuan; Chunyang Zhang; Weijun Fu; Hua Jiang; Baoan Chen; Jian Hou
Journal:  Leuk Res       Date:  2010-01-31       Impact factor: 3.156

8.  Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.

Authors:  Kaspar René Nielsen; Maria Rodrigo-Domingo; Rudi Steffensen; John Baech; Kim S Bergkvist; Liesbeth Oosterhof; Alexander Schmitz; Julie Støve Bødker; Preben Johansen; Ulla Vogel; Anette Vangsted; Karen Dybkær; Martin Bøgsted; Hans Erik Johnsen
Journal:  Leuk Lymphoma       Date:  2017-04-09

9.  Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma.

Authors:  I Aladzsity; M Kovács; A Semsei; A Falus; A Szilágyi; I Karádi; G Varga; G Füst; J Várkonyi
Journal:  Leuk Res       Date:  2009-04-29       Impact factor: 3.156

10.  Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.

Authors:  Brenda M Birmann; Rulla M Tamimi; Edward Giovannucci; Bernard Rosner; David J Hunter; Peter Kraft; Constantine Mitsiades; Kenneth C Anderson; Graham A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.